Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD (Lp(a)HORIZON)
Brief description of study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
dyslipidemia,hyperlipidemia,myocardial infarction,stroke,peripheral artery disease,hypercholesterolemia,elevated Lp(a)
-
Age: Between 18 Years - 80 Years
-
Gender: All
Male and Female Age 18-80 Lp(a) ≥ 70 mg/dL Myocardial infarction: ≥ 3 months Ischemic stroke: ≥ 3 months significant symptomatic peripheral artery disease
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting